Nektar Therapeutics (Germany) Analysis
| ITH Stock | EUR 1.61 0.07 4.17% |
Nektar Therapeutics is overvalued with Real Value of 1.14 and Hype Value of 1.61. The main objective of Nektar Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Nektar Therapeutics is worth, separate from its market price. There are two main types of Nektar Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Nektar Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Nektar Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Nektar Therapeutics stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Nektar Therapeutics is usually not traded on Christmas Day, Boxing Day, New Year 's Day, Good Friday, Easter Monday, International Workers ' Day, GermanUnityDay. Nektar Stock trading window is adjusted to Europe/Berlin timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Nektar Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
Nektar |
Nektar Stock Analysis Notes
About 92.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.32. Some equities with similar Price to Book (P/B) outperform the market in the long run. Nektar Therapeutics recorded a loss per share of 2.27. The entity had not issued any dividends in recent years. Nektar Therapeutics develops drug candidates for cancer, auto-immune disease, and chronic pain in the United States. Nektar Therapeutics was founded in 1990 and is headquartered in San Francisco, California. NEKTAR THERAPEUTICS operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 618 people. To learn more about Nektar Therapeutics call Howard Robin at 415 482 5300 or check out https://www.nektar.com.Nektar Therapeutics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Nektar Therapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Nektar Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Nektar Therapeutics is way too risky over 90 days horizon | |
| Nektar Therapeutics may become a speculative penny stock | |
| Nektar Therapeutics appears to be risky and price may revert if volatility continues | |
| Nektar Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 101.91 M. Net Loss for the year was (523.84 M) with profit before overhead, payroll, taxes, and interest of 77.01 M. | |
| Nektar Therapeutics has accumulated about 1.52 B in cash with (412.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.68, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 92.0% of the company shares are owned by institutional investors |
Nektar Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 268.37 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nektar Therapeutics's market, we take the total number of its shares issued and multiply it by Nektar Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 16th of May 2024, Nektar Therapeutics secures the Downside Deviation of 5.33, risk adjusted performance of 0.1449, and Mean Deviation of 5.77. Nektar Therapeutics technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for Nektar Therapeutics, which can be compared to its peers in the industry. Please verify Nektar Therapeutics standard deviation, treynor ratio, downside variance, as well as the relationship between the information ratio and value at risk to decide if Nektar Therapeutics is priced some-what accurately, providing market reflects its recent price of 1.61 per share.Nektar Therapeutics Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Nektar Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Nektar Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Nektar Therapeutics Predictive Daily Indicators
Nektar Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Nektar Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.96 | |||
| Day Median Price | 1.61 | |||
| Day Typical Price | 1.61 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.07) | |||
| Relative Strength Index | 68.1 |
Nektar Therapeutics Forecast Models
Nektar Therapeutics' time-series forecasting models are one of many Nektar Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nektar Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Nektar Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Nektar Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nektar shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Nektar Therapeutics. By using and applying Nektar Stock analysis, traders can create a robust methodology for identifying Nektar entry and exit points for their positions.
Nektar Therapeutics develops drug candidates for cancer, auto-immune disease, and chronic pain in the United States. Nektar Therapeutics was founded in 1990 and is headquartered in San Francisco, California. NEKTAR THERAPEUTICS operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 618 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Nektar Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Price Exposure Probability Now
Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets |
| All Next | Launch Module |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Nektar Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Nektar Stock please use our How to Invest in Nektar Therapeutics guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Nektar Stock analysis
When running Nektar Therapeutics' price analysis, check to measure Nektar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nektar Therapeutics is operating at the current time. Most of Nektar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nektar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nektar Therapeutics' price. Additionally, you may evaluate how the addition of Nektar Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |